Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8554 |
High Similarity |
NPD7075 |
Discontinued |
0.8494 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8485 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8415 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8373 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8333 |
Intermediate Similarity |
NPD2532 |
Approved |
0.8333 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8333 |
Intermediate Similarity |
NPD2533 |
Approved |
0.8333 |
Intermediate Similarity |
NPD2534 |
Approved |
0.8314 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8313 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8303 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8294 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8263 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.825 |
Intermediate Similarity |
NPD2800 |
Approved |
0.8235 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8218 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8204 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8182 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8177 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.8161 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8156 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.815 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.815 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.815 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.814 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8107 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8049 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8047 |
Intermediate Similarity |
NPD2801 |
Approved |
0.8012 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8011 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8 |
Intermediate Similarity |
NPD5402 |
Approved |
0.8 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7978 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7963 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7952 |
Intermediate Similarity |
NPD1512 |
Approved |
0.795 |
Intermediate Similarity |
NPD6100 |
Approved |
0.795 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7933 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7921 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7901 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7901 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7888 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7866 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7866 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7865 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7853 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7853 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7849 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.784 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7833 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7831 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7811 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7809 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7798 |
Intermediate Similarity |
NPD5403 |
Approved |
0.779 |
Intermediate Similarity |
NPD8313 |
Approved |
0.779 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7784 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7778 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7771 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7765 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7764 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7764 |
Intermediate Similarity |
NPD6651 |
Approved |
0.776 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7749 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7727 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7727 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7722 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7719 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7701 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7684 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7684 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7684 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7684 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7684 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7684 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7684 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7684 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7679 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7657 |
Intermediate Similarity |
NPD5537 |
Clinical (unspecified phase) |
0.7657 |
Intermediate Similarity |
NPD919 |
Approved |
0.7651 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7644 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.764 |
Intermediate Similarity |
NPD1240 |
Approved |
0.763 |
Intermediate Similarity |
NPD5761 |
Phase 2 |
0.763 |
Intermediate Similarity |
NPD5760 |
Phase 2 |
0.7581 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7576 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7572 |
Intermediate Similarity |
NPD37 |
Approved |
0.7565 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7565 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7565 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7557 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7551 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7543 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7543 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7543 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7542 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7541 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7529 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7528 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7526 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7526 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7516 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7515 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7514 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7513 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7513 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7486 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7485 |
Intermediate Similarity |
NPD920 |
Approved |
0.7475 |
Intermediate Similarity |
NPD7801 |
Approved |
0.7471 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.747 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.747 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7459 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7444 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7436 |
Intermediate Similarity |
NPD8319 |
Approved |
0.7436 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.7435 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.743 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7421 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7421 |
Intermediate Similarity |
NPD6534 |
Approved |
0.741 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.741 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7399 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7399 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7396 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7396 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7381 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7381 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7374 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7368 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7349 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7349 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7349 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7337 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7337 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7326 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7322 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.732 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7317 |
Intermediate Similarity |
NPD8366 |
Approved |
0.7317 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7297 |
Intermediate Similarity |
NPD6765 |
Approved |
0.7297 |
Intermediate Similarity |
NPD6764 |
Approved |
0.7294 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7273 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7267 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7262 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7262 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7251 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7245 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7233 |
Intermediate Similarity |
NPD7907 |
Approved |
0.722 |
Intermediate Similarity |
NPD4111 |
Phase 1 |
0.722 |
Intermediate Similarity |
NPD4665 |
Approved |
0.7214 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7214 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7212 |
Intermediate Similarity |
NPD943 |
Approved |
0.7195 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7182 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7177 |
Intermediate Similarity |
NPD8491 |
Approved |
0.7174 |
Intermediate Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.7169 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7168 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7157 |
Intermediate Similarity |
NPD3057 |
Approved |
0.715 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.715 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.715 |
Intermediate Similarity |
NPD8155 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD6784 |
Approved |
0.7143 |
Intermediate Similarity |
NPD6785 |
Approved |
0.7135 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7134 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7122 |
Intermediate Similarity |
NPD8404 |
Phase 2 |
0.7113 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7113 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7112 |
Intermediate Similarity |
NPD3658 |
Clinical (unspecified phase) |
0.7112 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7108 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7108 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7107 |
Intermediate Similarity |
NPD2493 |
Approved |
0.7107 |
Intermediate Similarity |
NPD2494 |
Approved |
0.7099 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7093 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7091 |
Intermediate Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.7091 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7091 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7086 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7085 |
Intermediate Similarity |
NPD4582 |
Approved |
0.7085 |
Intermediate Similarity |
NPD4583 |
Approved |
0.7081 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7081 |
Intermediate Similarity |
NPD7799 |
Discontinued |
0.7076 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7071 |
Intermediate Similarity |
NPD2972 |
Approved |
0.7071 |
Intermediate Similarity |
NPD3533 |
Approved |
0.7059 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7052 |
Intermediate Similarity |
NPD7236 |
Approved |
0.7042 |
Intermediate Similarity |
NPD8067 |
Phase 3 |
0.7037 |
Intermediate Similarity |
NPD6696 |
Suspended |
0.7035 |
Intermediate Similarity |
NPD4004 |
Approved |
0.7035
|
Intermediate Similarity |
NPD4002 |
Approved |